
ProKidney Corp.: updates and filings
Price
$1.04
November 20, 2026Market cap $218M
What Ploutos Investor adds for ProKidney
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 12, 2026next Feb 11, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
August 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Results of operationsForm8-K
- Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 10, 2026FilingFormEFFECT
- Nov 9, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Oct 29, 2026Material agreement enteredForm8-K
- Oct 29, 2026Shelf registration for future offeringsFormS-3
- Aug 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 10, 2026Results of operationsForm8-K
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- May 29, 2026Shareholder voteForm8-K
- May 15, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- May 15, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Apr 17, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 17, 2026Additional annual meeting materialFormDEFA14A
- Apr 17, 2026Annual meeting proxy statementFormDEF 14A
- Mar 18, 2026Shares registered for employeesFormS-8
- Mar 18, 2026Results of operationsForm8-K
- Mar 18, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 12, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Feb 2, 2026Regulation FD disclosure, other material eventsForm8-K
- Jan 12, 2026Regulation FD disclosureForm8-K
- Nov 18, 2025FilingFormEFFECT
- Nov 10, 2025Results of operationsForm8-K
- Nov 10, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | 8-K | Results of operations | Document |
| Nov 12, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 10, 2026 | EFFECT | Filing | Document |
| Nov 9, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Oct 29, 2026 | 8-K | Material agreement entered | Document |
| Oct 29, 2026 | S-3 | Shelf registration for future offerings | Document |
| Aug 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| May 29, 2026 | 8-K | Shareholder vote | Document |
| May 15, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| May 15, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Apr 17, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 17, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 17, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 18, 2026 | S-8 | Shares registered for employees | Document |
| Mar 18, 2026 | 8-K | Results of operations | Document |
| Mar 18, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 12, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Feb 2, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jan 12, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 18, 2025 | EFFECT | Filing | Document |
| Nov 10, 2025 | 8-K | Results of operations | Document |
| Nov 10, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 21, 2021.
The full analysis
What do ProKidney's filings show?
The filings are where every one of ProKidney's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.